TrialBlood2026
Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.
Enise Ceran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2026
this papercites it